Overview

Safety And Efficacy Of Exubera Compared With Subcutaneous Human Insulin Therapy In Children And Adolescents

Status:
Terminated
Trial end date:
2007-10-01
Target enrollment:
Participant gender:
Summary
To assess the safety and efficacy of Exubera on pulmonary function and glycemic control in subjects ages 6-17 over a 1 year period.
Phase:
Phase 3
Details
Lead Sponsor:
Pfizer
Treatments:
Insulin
Insulin, Globin Zinc